CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-20 | Colangelo Dominick President and CEO | Option exercise · Option (right to buy) | −27,500 | 412,500 | ||
| 2018-02-20 | Colangelo Dominick President and CEO | Option exercise · Option (right to buy) | −6,603 | 48,397 | ||
| 2018-02-07 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2018-02-07 | Colangelo Dominick President and CEO | Grant or award · Option (right to buy) | +300,000 | 300,000 | ||
| 2018-02-07 | Orlando Daniel Chief Operating Officer | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2017-05-22 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-05-22 | Orlando Daniel Chief Operating Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2017-05-22 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2017-05-03 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-05-03 | ZERBE ROBERT L MD Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-05-03 | Wotton Paul K Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-05-03 | Rubino Alan L Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-05-03 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-05-03 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2017-02-08 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Option (right to buy) | +38,298 | 38,298 | ||
| 2017-02-08 | MICHEL GERARD J CFO and VP, Corp. Development | Grant or award · Option (right to buy) | +31,702 | 31,702 | ||
| 2017-02-08 | Colangelo Dominick President and CEO | Grant or award · Option (right to buy) | +42,175 | 42,175 | ||
| 2017-02-08 | Colangelo Dominick President and CEO | Grant or award · Option (right to buy) | +167,825 | 167,825 | ||
| 2017-02-08 | Orlando Daniel Chief Operating Officer | Grant or award · Option (right to buy) | +30,878 | 30,878 | ||
| 2017-02-08 | Orlando Daniel Chief Operating Officer | Grant or award · Option (right to buy) | +39,122 | 39,122 |
Page 66 of 75 · 1,497 trades